Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00077428
Brief Title: Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck

First Submitted : February 10, 2004
First Submitted that Met QC Criteria : February 11, 2004
First Posted : February 12, 2004 (Estimate)

Last Update Submitted that Met QC Criteria : January 23, 2013
Last Update Posted : January 24, 2013 (Estimate)